CFF ResearchCon 2023 Annouonced
The Cystic Fibrosis Foundation has announced the 2023 edition of their ResearchCon program. Here’s the announcement: ResearchCon is for everyone with a personal or professional connection to cystic fibrosis to […]
CFFC Facebook Posts Week of 03/05
Seven posts were made to the CFFC Facebook page during the week of 3/5-11/2023. 03/05/2023 – How does cystic fibrosis affect the body? Want quick facts on how CF manifests […]
CFFC Facebook Posts Week of 2/26
Seven posts were made to the CFFC Facebook page during the week of 2/26-3/4/2023. 02/26/2023 – E-cigarettes, marijuana of ‘growing popularity’ among younger patients – The legalization of marijuana and […]
CFFC Facebook Posts Week of 2/19
Six posts were made to the CFFC Facebook page during the week of 2/19-25/2023. 02/20/2023 – In-school treatment may improve health outcomes for CF children – At first glance, this […]
CFFC Facebook Posts Week of 2/12
Six posts were made to the CFFC Facebook page during the week of 2/12-18/2023. 02/12/2023 – What those of us with invisible diseases want others to know – Here’s a […]
CFFC Facebook Posts Week of 2/5
Seven posts were made to the CFFC Facebook page during the week of 2/5-11/2023. 02/05/2023 – Personal patient story – Cystic Fibrosis – This story comes from Israel. The details […]
CFFC Facebook Posts Week of 1/29
Five posts were made to the CFFC Facebook page during the week of 1/29-2/4/2023. 01/30/2023 – How Family Relationships Have Grown Along With Day-to-Day Life – This story demonstrates the […]
CFFC Facebook Posts Week of 1/22
Eight posts were made to the CFFC Facebook page during the week of 1/22-28/2023. 01/22/2023 – Cystic Fibrosis: Amber’s Story – We all know people who earn the title of […]
CFFC Facebook Posts Week of 1/15
Seven posts were made to the CFFC Facebook page during the week of 1/15-21/2023. 01/15/2023 – Why Walter White of ‘Breaking Bad’ Is Relevant to the CF Community – Here […]
Clinical Trial Alert 01/19/2023
Cystic Fibrosis Foundation issued three clinical trial alerts on 01/19/2023: two enrolling, one results Study to evaluate VX-522 in adults 18 years and older with cystic fibrosis. Status: Enrolling Description: […]